Both in Pharmaceuticals
Rhythm Pharmaceuticals vs Alkermes
Over the past year RYTM returned −4.9% and ALKS returned +40.5%; their daily moves had a correlation of 0.38.
RYTM −4.9% ALKS +40.5%Growth of $1, one year, split-adjusted
| Metric | RYTM | ALKS |
|---|---|---|
| Price | $95.71 | $40.80 |
| Market cap | $6.59B | $6.84B |
| Today | −2.89% | +1.62% |
| 1 month | −10.7% | −13.9% |
| 6 months | +23.9% | +35.3% |
| Year to date | −10.6% | +45.8% |
| 1 year | −3.5% | +46.3% |
| Revenue growth (YoY) | +46.9% | +27.0% |
| Gross margin | 87.5% | 80.2% |
| Net margin | −70.7% | 0.1% |
| P/E (TTM) | — | 103.5× |
| Price / sales | 27.5× | 4.1× |
| Net cash | $224.8M | -$846.5M |
| Dividend yield | — | — |
| Volatility (60d) | 38.4% | 30.5% |
| Short % of float | 16.0% | 9.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).